Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
Psyched：LSD 治療重度抑鬱症、加拿大的 psilocybin 大劑量試驗、多發性硬化症的治療方法等
LSD Trial Study Shows Potential For Major Depression
LSD 試驗研究顯示可能出現重度抑鬱症
Psychedelics biopharma company Mind Medicine Inc. (NASDAQ:MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a treatment of Major Depressive Disorder (MDD).
The double-blind Phase 2 study demonstrated "significant, rapid, durable and beneficial effects" on the mitigation of MDD symptoms. Read more HERE.
迷幻生物製藥公司 Mind Medicine公司 納斯達克股票代碼：MNMD）最近分享了來自迷幻藥高級臨牀試驗的積極頭條數據 作爲重度抑鬱症（MDD）的治療方法。
雙盲2期研究表明，對緩解MDD症狀有 “顯著、快速、持久和有益的作用”。 在這裏閱讀更多。
Canada's Large Scale Psilocybin Macrodose Trial
加拿大大規模的 psilocybin 大劑量試驗
Canadian biopharma company Apex Labs Ltd., has received Health Canada's approval for a comprehensive, "statistically powered" macro-and-multi dose advanced psilocybin trial on 160 patients.
The trial's primary indication (severe depression within PTSD) is...
加拿大生物製藥公司 Apex Labs Ltd. 已獲得加拿大衛生部的批...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間